China Post-marketing Surveillance (PMS) Study of Aldurazyme®
Condition(s):Mucopolysaccharidosis ILast Updated:September 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Mucopolysaccharidosis ILast Updated:September 28, 2023Completed
Condition(s):Hurler SyndromeLast Updated:March 20, 2020Completed
Condition(s):Mucopolysaccharidosis I; Hurler’s Syndrome; Hurler-Scheie Syndrome; ScheieLast Updated:February 20, 2024Terminated
Condition(s):Mucopolysaccharidosis Type IH; MPS I; Hurler SyndromeLast Updated:September 27, 2018Terminated
Condition(s):Mucopolysaccharidosis I; Hurler’s Syndrome; Hurler-Scheie Syndrome; Scheie SyndromeLast Updated:April 3, 2015Completed
Condition(s):Hematopoietic Cell Transplantation; Mucopolysaccharidosis Type ILast Updated:November 30, 2023Recruiting
Condition(s):Mucopolysaccharidosis I; Hurler Syndrome; Hurler-Scheie Syndrome; Scheie SyndromeLast Updated:April 3, 2015Completed
Condition(s):Mucopolysaccharidosis ILast Updated:July 2, 2014Completed
Condition(s):Mucopolysaccharidosis I; Hurler SyndromeLast Updated:July 11, 2019Completed
Condition(s):Mucopolysaccharidosis I; Hurler’s Syndrome; Hurler-Scheie Syndrome; Scheie’s SyndromeLast Updated:May 5, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.